Filter
181
Text search:
non-endemic
countries
Featured
Recommendations
28
New Publications
43
Language
Document type
No document type
74
Studies & Reports
43
Guidelines
39
Manuals
8
Strategic & Response Plan
7
Training Material
3
Fact sheets
3
Situation Updates
2
Resource Platforms
1
Infographics
1
Countries / Regions
Global
17
Latin America and the Carribbean
11
Congo, Democratic Republic of
6
Madagascar
6
Ethiopia
5
India
5
Africa
5
Pakistan
4
West and Central Africa
4
Guinea
3
Nigeria
3
Afghanistan
3
South Africa
3
Middle East and North Africa
3
Western and Central Europe
3
Cameroon
2
Ghana
2
Uganda
2
Philippines
2
Syria
2
Bangladesh
2
Colombia
2
Botswana
2
East and Southern Africa
2
Venezuela
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Somalia
1
Germany
1
Turkey
1
Chad
1
Rwanda
1
Indonesia
1
Mozambique
1
Central African Republic
1
Angola
1
Lesotho
1
Mexico
1
Myanmar / Burma
1
Western Pacific Region
1
Eastern Europe
1
North America
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
45
Countries
44
Public Health
18
Women & Child Health
5
Key Resources
5
Pharmacy & Technologies
3
Capacity Building
1
Toolboxes
NTDs
64
Rapid Response
33
Polio
7
Cholera
5
Planetary Health
5
Ebola
4
Global Health Education
3
Zika
2
Mental Health
2
Disability
1
Conflict
1
Natural Hazards
1
Refugee
1
HIV
1
TB
1
Specific Hazards
1
AMR
1
COVID-19
1
Pharmacy
1
Health Financing Toolbox
1
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po
...
Chagas disease (CD) is endemic in the Americas, being present in 21 countries, where it affects about 6 million
people.(1) With such relevant numbers of people affected and disability adjusted life years lost, CD is a poverty-related
and poverty-p
...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countr
...
A key purpose of the Recovery Toolkit is to support countries in the reactivation of health services which may have suffered as a result of the emergency. These services include ongoing programmes such as immunization and vaccinations, maternal and
...
The EYE strategy is a comprehensive and long-term strategy built on lessons learned that aims at ending yellow fever epidemics by 2026, and consists of three strategic objectives:
protect at-risk populations;
prevent international spread; and
contain outbreaks rapidly.
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t
...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande
...
With this World Health Day, WHO is drawing attention to a group of diseases that are spread by insects and other vectors, the heavy health and economic burdens they impose, and what needs to be done to reduce these burdens. Many of these diseases have been historically confined to distinct geographi
...
This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national yaws eradication programmes and WHO technical sta
...
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and disorders that could be linked to it, improve vector control, effectively communicate risks, guidance an
...
During the past five decades, the incidence of dengue has increased 30-fold. Some 50–100 million new infections are estimated to occur annually in more than 100 endemic countries, with a documented further spread to previously unaffected areas; e
...
The marathon to eradicate polio is on its final lap: the world is more than 99% of the way to success. After millennia of living with poliovirus and suffering the paralysis it causes, today nearly all the world’s people live in polio-free countries
...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p
...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde
...
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes
The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the selection of blood donors and the collection, processing and testing of blood donations to the testing of patient samples, the issue of compatible blood and
...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan
...
The main objectives of the SOPs are to: (i) establish standards and timelines for response activities; and (ii) guide national governments and GPEI partners in key support functions.
This new version of the SOPs presents overall response requirements for dealing with type 1, 2 and 3 poliovirus fo
...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradicatio
...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution
...
